The specifics of the 18% absolute benefit mark...Need to be explained. The discussion around additional cycles of PMX is wonderful, but let's see if we get an approval for abdominal treatment right off the bat ( Go Jays Go !)
This important detail failed to reach Bengaluru and Ms. Grover - "that's a shame" - ; - )
- Clinical data demonstrates a positive benefit for patients in septic shock - Significant improvement in cardiovascular function was observed - Mortality benefit in the pre specified per protocol patient population with a MODS score greater than nine was 5% - Mortality benefit increased significantly as a function of the amount of endotoxin removed, reaching 18% - Company plans to meet with FDA to discuss regulatory pathway